Welcome to our dedicated page for Dss news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on Dss stock.
DSS, Inc. (NYSE American: DSS) generates news across a wide range of sectors, reflecting its role as a multinational company with diversified business lines in packaging, biohealth innovation, financial services, alternative trading, and real estate. The company’s press releases and regulatory disclosures highlight strategic transactions, capital markets developments, operational milestones, and portfolio optimization efforts.
News about DSS often covers corporate strategy and portfolio management, including spin-offs, asset sales, and transactions involving key subsidiaries. Examples include the sale of the Celios air purification asset to Impact BioMedical Inc., as well as a definitive merger agreement under which Impact BioMedical will be acquired through a reverse merger with Dr. Ashleys Limited, resulting in a new public company. These items illustrate DSS’s stated approach of unlocking value by advancing subsidiaries toward independent public listings and other exit opportunities.
Investors and followers of DSS can also expect updates on financial performance and corporate actions. The company reports on revenue trends, cash flow improvements, debt reduction, and asset monetization, such as the sale of a real estate facility and growth in rental income. Leadership communications, including letters to shareholders and announcements of executive appointments, provide additional context on strategic priorities, cost reduction initiatives, and the focus on core growth verticals.
Because DSS has subsidiaries in securities and investment management, its news flow includes developments at entities like Sentinel Brokers Company, Inc. and AmericaFirst Funds. These updates may involve regulatory approvals, such as FINRA authorization for underwriting activities, changes to mutual fund boards, and expansion of capital markets capabilities. For a comprehensive view of DSS-related developments, readers can use this news page to follow corporate strategy, subsidiary activity, and key financial and regulatory events over time.
Document Security Systems (DSS) announced a bioplastics research collaboration through its subsidiary Impact BioMedical. The partnership aims to develop five types of advanced microbial-resistant plastics to combat pathogens like SARS-CoV-2 and E. coli. Daryl Thompson, a noted researcher and twice Nobel nominee, is leading the project, targeting completion in Q4. This initiative leverages GRDG Sciences' expertise and addresses the growing market demand for microbial-resistant consumer products. DSS emphasizes the importance of this research in meeting an increasing consumer awareness of health safety.
Document Security Systems (DSS) announced a three-year contract for approximately $10 million with a leading photography company, enhancing its Premier Packaging subsidiary's portfolio. The contract, valued at around $3.2 million annually, highlights the client's confidence in Premier's capabilities and could lead to further business opportunities. Since management changes in July 2019, Premier has improved operations through investments in manufacturing and processes. As a market leader in secure printing and packaging, Premier services diverse industries, showcasing its adaptable customer service approach.
Document Security Systems (DSS) has announced a special dividend, granting shareholders two shares of Impact BioMedical for each share of DSS held as of September 7, 2020. A second tranche is anticipated but lacks a set record date. The recent acquisition of Impact BioMedical, valued at $382 million, enhances DSS's position in the biomedical field, focusing on R&D for antiviral and medical technologies. This strategic move aims to leverage Impact BioMedical’s assets to improve shareholder value and drive future growth.
Document Security Systems (DSS) announces an upcoming interview with COO Jason Grady on The RedChip Money Report, airing August 30 at 6 p.m. on Bloomberg International, reaching over 100 million homes in Europe. The interview will delve into DSS's diverse operations, including the recent acquisition of Impact BioMedical and growth strategies aimed at benefiting shareholders. The segment will also be available in the U.S. on multiple channels, showcasing insights into small-cap investment strategies and executive perspectives.
DSS has officially closed its acquisition of Impact BioMedical, marking a significant milestone for the company. This acquisition is expected to enhance DSS’s brand protection technology and healthcare sectors. DSS plans to take Impact BioMedical public through an IPO, along with a proposed two-part bonus share dividend for DSS shareholders, offering four Impact shares for each DSS share owned. Impact BioMedical’s technologies have been independently valued between $382 million and $933 million, suggesting potential growth in the healthcare market.
Document Security Systems (DSS) reported Q2 2020 financial results, showing a revenue of $3.1 million, down 10% from $3.5 million in Q2 2019 due to COVID-19 impacts. The net loss narrowed to $672,000, or $0.19 per share, compared to a loss of $732,000 in the previous year. DSS strengthened its balance sheet with $16.1 million raised in offerings. A significant contract worth over $24 million was signed by DSS's Premier Packaging subsidiary. DSS also advanced its acquisition of Impact BioMedical, focusing on diversification and shareholder value.
Document Security Systems (NYSE American: DSS) has successfully completed a public offering of 453,333 shares at $7.50 each, raising gross proceeds of $3.4 million. The funds will support growth in new business lines, acquisition opportunities, and general corporate expenses. Additionally, the underwriter has a 45-day option to purchase 38,533 more shares. This offering was conducted under an effective shelf registration statement with the SEC, aiming to enhance DSS's business operations in brand protection technology and blockchain security.
Document Security Systems (NYSE American: DSS) announced the pricing of a public offering of 453,333 shares at $7.50 per share, aiming for gross proceeds of $3.4 million. The funds will support the growth of new business lines, acquisition opportunities, and general corporate needs. An additional 38,533 shares may be purchased by the underwriter to cover over-allotments. The offering is set to close on July 31, 2020, pending customary conditions. Aegis Capital Corp. is the sole book-running manager for this offering.
Document Security Systems (DSS) announces the launch of its AuthentiGuard as a Service (AGaaS) app, now available on The App Store. This innovative solution targets counterfeit issues faced by brands, enabling manufacturers to authenticate products and engage consumers efficiently. AGaaS offers real-time tracking to ensure product authenticity, coupled with augmented reality marketing features. DSS will host a webinar on July 22, 2020, to showcase AGaaS and invite brand participation. This move enhances DSS's position in brand protection and consumer engagement, reinforcing its market strategy.
Document Security Systems (DSS) announced an update on its acquisition of Impact BioMedical, initially disclosed on April 27, 2020. Shareholders of DSS are set to vote on August 10, 2020, with shareholder approval being the last requirement for completion. The acquisition aligns with DSS’s strategy to distribute Impact shares post-IPO, where shareholders could receive four Bonus shares for each DSS share held. Although intended, DSS cannot guarantee public listing of Impact BioMedical or the Bonus share distribution, as these depend on future conditions.
FAQ
What is the current stock price of Dss (DSS)?
What is the market cap of Dss (DSS)?
